BBOT
Price
$9.29
Change
-$0.01 (-0.11%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
748.41M
6 days until earnings call
VTGN
Price
$3.24
Change
+$0.06 (+1.89%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
99.1M
Interact to see
Advertisement

BBOT vs VTGN

Header iconBBOT vs VTGN Comparison
Open Charts BBOT vs VTGNBanner chart's image
BridgeBio Oncology Therapeutics
Price$9.29
Change-$0.01 (-0.11%)
Volume$13.32K
Capitalization748.41M
VistaGen Therapeutics
Price$3.24
Change+$0.06 (+1.89%)
Volume$2.99K
Capitalization99.1M
BBOT vs VTGN Comparison Chart in %
Loading...
BBOT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BBOT vs. VTGN commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BBOT is a Buy and VTGN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (BBOT: $9.30 vs. VTGN: $3.23)
Brand notoriety: BBOT and VTGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BBOT: 133% vs. VTGN: 57%
Market capitalization -- BBOT: $748.41M vs. VTGN: $99.1M
BBOT [@Biotechnology] is valued at $748.41M. VTGN’s [@Biotechnology] market capitalization is $99.1M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BBOT’s FA Score shows that 1 FA rating(s) are green whileVTGN’s FA Score has 0 green FA rating(s).

  • BBOT’s FA Score: 1 green, 4 red.
  • VTGN’s FA Score: 0 green, 5 red.
According to our system of comparison, VTGN is a better buy in the long-term than BBOT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BBOT’s TA Score shows that 2 TA indicator(s) are bullish while VTGN’s TA Score has 4 bullish TA indicator(s).

  • BBOT’s TA Score: 2 bullish, 4 bearish.
  • VTGN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BBOT is a better buy in the short-term than VTGN.

Price Growth

BBOT (@Biotechnology) experienced а -3.43% price change this week, while VTGN (@Biotechnology) price change was +5.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.10%. For the same industry, the average monthly price growth was +14.72%, and the average quarterly price growth was +30.35%.

Reported Earning Dates

BBOT is expected to report earnings on Sep 03, 2025.

Industries' Descriptions

@Biotechnology (+2.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BBOT($748M) has a higher market cap than VTGN($99.1M). VTGN YTD gains are higher at: 9.492 vs. BBOT (-11.429).
BBOTVTGNBBOT / VTGN
Capitalization748M99.1M755%
EBITDAN/A-58.99M-
Gain YTD-11.4299.492-120%
P/E RatioN/AN/A-
RevenueN/A646K-
Total CashN/A63.2M-
Total DebtN/A2.36M-
FUNDAMENTALS RATINGS
VTGN: Fundamental Ratings
VTGN
OUTLOOK RATING
1..100
85
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BBOTVTGN
RSI
ODDS (%)
Bearish Trend 2 days ago
25%
Bearish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
33%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
8%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
4%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
5%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
12%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 11 days ago
16%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
N/A
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
BBOT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ANVMX10.77N/A
N/A
American Century Non-US Intrs ValR6
EZTGX55.42N/A
N/A
Eaton Vance Tx-Mgd Growth 1.2 C
RYMSX24.80N/A
N/A
Guggenheim Multi-Hedge Strategies P
ERSGX14.39N/A
N/A
Eaton Vance Small-Cap R
JEPIX14.15N/A
N/A
JPMorgan Equity Premium Income I

BBOT and

Correlation & Price change

A.I.dvisor tells us that BBOT and VKTX have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BBOT and VKTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BBOT
1D Price
Change %
BBOT100%
-2.97%
VKTX - BBOT
29%
Poorly correlated
+2.23%
SNGX - BBOT
26%
Poorly correlated
-4.46%
COCP - BBOT
25%
Poorly correlated
+0.32%
PRTC - BBOT
22%
Poorly correlated
-8.27%
VTGN - BBOT
21%
Poorly correlated
+2.58%
More